Common Sensing
|
HQ Location
United States
|
Year Founded
2012
|
Company Type
Private
|
Revenue
< $10m
|
|
Employees
11 - 50
|
Website
|
Twitter Handle
|
Common Sensing develops and manufactures data-driven hardware and software medical device solutions for diabetes care that foster education and communication for patients while delivering decision support for clinicians. Founded in 2012, Common Sensing has a team of talented designers and engineers to develop Gocap?, a smart cap that turns existing injector pens into smart injectors. Gocap connects insulin, GLP-1, fertility hormone, and human growth hormone injector pens to the cloud to improve outcomes and make everyday treatment more convenient.
CONNECTED CARE DESIGNED FOR EVERYONE Gocap is the smart cap for insulin pens. It’s small enough to fit in a pocket, and has a USB-rechargeable battery that lasts for a week. Gocap automatically generates an insulin logbook that can be wirelessly shared with care providers and family. Gocap provides a powerful way to reduce anxiety, get a leg up on compliance, and deliver better care.
-
Devices Layer
-
Edge Layer
-
Cloud Layer
-
Application Layer
-
Supporting Technologies
Supplier missing?
Start adding your own!
Register with your work email and create a new supplier profile for your business.
Similar Suppliers.
